Hepatitis C patients are taking insurance companies to court for denying them treatments.
Some patients have started suing insurers or state agencies that deny access to expensive new treatments for hepatitis C, charging that the insurers don’t want to fork over the money for the high-price drugs.
Lawsuits to force insurers to pay for a procedure aren’t new, but they could reflect a new reality for most insurers as they find a way to pay for high-priced drugs.
The latest lawsuit was filed on Thursday by a group of prisoners against the Massachusetts prison system for denying access to new hepatitis C drugs.
“Over 1,500 state prisoners in Massachusetts have hepatitis C, but as of the present time only three are being treated for it,” according to the lawsuit.